NTA per share hit record $0.85 on 7.7% portfolio return

Net assets attributable to shareholders reached NZ$225.9m, within the historical range but NZ$11.8m above the four-period mean of NZ$214.1m. The portfolio delivered a total return of 7.7% over the half, comfortably ahead of the 3.7% benchmark, and investment total return of NZ$17.3m sat at the upper edge of the supplied historical range.

Headline NPAT of NZ$14.9m fell 52.8% against a record HY21 of NZ$31.6m, and PBT was down 50.3%. Cash dividend and interest income totalled NZ$1.9m, below the historical baseline range of NZ$2.0m-NZ$2.4m. The board declared a 1.68cps quarterly dividend; total distributions paid during the half were 3.5cps (NZ$5.5m).

At $0.85, NTA per share is $0.16 above its four-period historical mean and outside the prior range. The 7.7% portfolio return (within historical norms) materially outpaced the 3.7% benchmark, though that benchmark was itself an unprecedented low against a 5.6%-10.7% historical range. The 4pp manager outperformance matters, but readers should weight it against a softer benchmark half rather than reading it as a normalised alpha figure.

Distribution coverage is structurally light. Distributions paid during the half (NZ$5.5m) imply roughly 35% coverage on the supplied basis, and cash investment income of NZ$1.9m alone funds only a fraction of the payout. This is consistent with a listed investment company drawing distributions partly from realised capital returns, but it means the payout depends on continued portfolio gains rather than recurring dividend and interest income.

The 53% NPAT decline is not a like-for-like read on portfolio health. HY21 was a record half dominated by recovery-phase fair-value gains. NPAT growth of -52.8% sits within the company's own historical range (mean -74.8%), and ROE of 6.6% is at the upper edge of the four-period range (mean 2.7%). The half is a solid result against the longer track record, not a deterioration.

The read is therefore limited to what the release does support: NTA is at a record level, the manager beat its benchmark by 4pp in a weak benchmark half, and distributions continue to require capital return support rather than running on natural portfolio income. There is no basis in the supplied context to project second-half NAV, portfolio composition shifts, or whether the alpha persists in a more normal benchmark environment.

Investment total return of NZ$17.3m is overwhelmingly portfolio gains; the NZ$1.9m of cash investment income (below the historical range) provides limited buffer if portfolio gains reverse in a weaker market.

The NZ$23.8m operating cash outflow reflects portfolio purchase activity rather than earnings quality, and is not informative through an operating-business lens. The balance sheet is essentially unlevered, with total liabilities of NZ$2.0m against NZ$227.9m of assets, so NAV movements translate cleanly to per-share NAV without leverage amplification or compression. ROE of 6.6%, at the upper edge of the historical range against a mean of 2.7%, supports the view that per-share economics for the half were genuinely good, even though the HY21 comparison is misleading on its face.

This briefing cannot assess portfolio composition, sector and geographic exposures, the expense ratio, or the realised-versus-unrealised split of investment gains, because those disclosures were not in the supplied context.